Lifestyle risk factors for hepatocellular carcinoma in treated chronic hepatitis C patients

被引：0
作者：
Matsuura, Tomoka [1 ,2 ]
Ohfuji, Satoko [1 ]
Enomoto, Masaru [2 ]
Tamori, Akihiro [2 ]
Kubo, Shoji [3 ]
Kioka, Kiyohide [4 ]
Fukushima, Wakaba [1 ]
机构：
[1] Osaka City Univ, Dept Publ Hlth, Grad Sch Med, Osaka, Japan
[2] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka, Japan
[3] Osaka City Univ, Dept Hepatobiliary Pancreat Surg, Grad Sch Med, Osaka, Japan
[4] Osaka City Gen Hosp, Dept Hepatol, Osaka, Japan
来源：
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY | 2021年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
670
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Risk assessment of hepatocellular carcinoma in chronic hepatitis C patients by transient elastography
    Masuzaki, Ryota
    Tateishi, Ryosuke
    Yoshida, Haruhiko
    Yoshida, Hideo
    Sato, Shinpei
    Kato, Naoya
    Kanai, Fumihiko
    Sugioka, Yosuke
    Ikeda, Hitoshi
    Shiina, Shuichiro
    Kawabe, Takao
    Omata, Masao
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2008, 42 (07) : 839 - 843
  • [32] Role of Ethnicity in Risk for Hepatocellular Carcinoma in Patients With Chronic Hepatitis C and Cirrhosis
    Nguyen, Mindie H.
    Whittemore, Alice S.
    Garcia, Ruel T.
    Tawfeek, Saraa A.
    Ning, Jing
    Lam, Suzanna
    Wright, Teresa L.
    Keeffe, Emmet B.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (09) : 820 - 824
  • [33] The risk factors for hepatocellular carcinoma development in patients with hepatitis C virus eradication
    Naito, Masafumi
    HEPATOLOGY, 2014, 60 : 693A - 693A
  • [34] Development of hepatocellular carcinoma in patients with chronic hepatitis C treated with interferon-alpha
    Mizokami, M
    Hirashima, N
    Sakakibara, K
    Orito, E
    Nakano, T
    Yamauchi, M
    Ueda, R
    Kage, M
    Kojiro, M
    Lau, JYN
    HEPATOLOGY, 1996, 24 (04) : 1080 - 1080
  • [35] METABOLIC RISK FACTORS INCREASE THE RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HEPATITIS C CIRRHOSIS
    Kutsenko, Alina
    Le, An K.
    Dang, Hansen
    Trinh, Sam
    Nguyen, Pauline
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2017, 152 (05) : S1077 - S1077
  • [36] Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the US
    Yang, Ming
    Parikh, Neehar D.
    Liu, Huixin
    Wu, Elizabeth
    Fu, Sherry
    Rao, Huiying
    Feng, Bo
    Lin, Andy
    Fei, Ran
    Wei, Lai
    Lok, Anna S.
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E852 - E852
  • [37] Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy
    Chang, Kuo-Chin
    Ye, Yi-Hao
    Wu, Cheng-Kun
    Lin, Ming-Tsung
    Tsai, Ming-Chao
    Tseng, Po-Lin
    Hu, Tsung-Hui
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2018, 117 (11) : 1011 - 1018
  • [38] Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B
    Chung Hwan Jun
    Hyoung Ju Hong
    Min Woo Chung
    Seon Young Park
    Sung Bum Cho
    Chang Hwan Park
    Young Eun Joo
    Hyun Soo Kim
    Sung Kyu Choi
    Jong Sun Rew
    World Journal of Gastroenterology, 2013, (40) : 6834 - 6841
  • [39] Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C
    Kumar, D
    Farrell, GC
    Kench, J
    George, J
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (09) : 1395 - 1400
  • [40] Type 2 Diabetes Mellitus and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals
    Laura, Iliescu Elena
    Letitia, Toma
    Camelia, Diaconu
    Anca, Zgura
    Nicolae, Bacalbasa
    Adriana, Mercan-Stanciu
    PROCEEDINGS OF 6TH INTERNATIONAL CONFERENCE ON INTERDISCIPLINARY MANAGEMENT OF DIABETES MELLITUS AND ITS COMPLICATIONS (INTERDIAB), 2020, : 150 - 155
12345